Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Acta Pharmaceutica Sinica ; (12): 3070-3075, 2023.
Article in Chinese | WPRIM | ID: wpr-999045

ABSTRACT

To discover new structural hits, based on the important role of pyrazole ring and fragment of pyridinone carboxylic acid in drug design, novel title pyrazolo[3,4-b]pyridine-4-one-5-carboxylic acid derivatives (10a-10p) were designed and synthesized, the structures were confirmed by spectral data and elemental analyses. The antibacterial and antitumor activities were evaluated by the measured minimum inhibitory concentration (MIC) values against the tested four strains and half inhibitory concentration (IC50) values against the tested four cancer cells, respectively. The results displayed markedly poor antibacterial activity and observably potent antitumor activity. In particularly, the title difluorophenyl (10d, 10e, 10f), pyridyl (10j), ethyl (10k) and cycloproyl (10l) compounds exhibited comparable activity against Capan-1 and A549 cells to that of the comparison doxorubicin. Thus, pyrazolo[3,4-b]pyridine-4-one-5-carboxylic acid derivatives as promising antitumor hits need to be developed.

2.
Chinese Journal of Epidemiology ; (12): 343-347, 2022.
Article in Chinese | WPRIM | ID: wpr-935393

ABSTRACT

Objective: To analyze the repetitive reporting of hepatitis B in Fujian province during 2016-2020, and provide evidence for the improvement of hepatitis B surveillance. Methods: The reporting cards from the China Information System for Disease Control and Prevention were collected and divided into repetitive reporting cards and non-repetitive reporting cards from the report cards collected according to the valid ID number on the cards, and the proportion of repetitive report cards and related factors were analyzed by using software SAS 9.4. Results: A total of 314 551 hepatitis B reporting cards were submitted in Fujian from 2016 to 2020, in which 90.93% (286 020/314 551) were included in the analysis. The repetitive reporting cards accounted for 10.48% (29 982/286 020). The annual proportion of the repetitive reporting cards from 2016 to 2020 was between 2.98% and 3.71%, showing an overall increasing trend year by year (Z=2.26, P=0.024). The proportions of the repetitive reporting cards in 1-5 years were 3.17%, 5.40%, 7.74%, 9.27% and 10.48%, respectively, showing an increase trend with year (Z=128.16, P<0.001). The proportions of the repetitive reporting cards in 10 areas of Fujian ranged from 5.44% to 13.48% with significant difference (χ2=2 050.41, P<0.001) and increased with the increase of reported incidence of hepatitis B (Z=26.92, P<0.001). There were significant differences in relationships between repetitive reporting proportion and sex, age and type of the cases between the areas with high incidence and low incidence of hepatitis B. Conclusions: The reported incidence of hepatitis B was seriously affected by the repetitive reporting in Fujian from 2016 to 2020. A cross-year and cross-area surveillance mechanism for hepatitis B should be established and targeted measures should be taken to strengthen the control of the repetitive reporting and improve the surveillance for hepatitis B.


Subject(s)
Humans , China/epidemiology , Data Collection , Hepatitis B/epidemiology , Incidence , Software
3.
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 245-250, 2021.
Article in Chinese | WPRIM | ID: wpr-906262

ABSTRACT

With the development of economic globalization and the increasingly complex international competition environment, pharmaceutical research and development has become the most powerful weapon for pharmaceutical companies to cope with the uncertainty of the competitive market. From the perspective of the pharmaceutical industry, based on the five-element theory, the article used the thinking of comparative state to carry out analogy research on the five-element theory and entrepreneur type system. Based on the entrepreneur type system and enterprise management system, the article embedded the enterprise senior management team system, and entrepreneurs were included in the system and assigned roles according to their different characteristics. Then through the analysis of the relationship between different entrepreneurs and the research and development (R&D) directors, the article expounded the influence of different types of entrepreneurs on the R&D process. The purpose of this study is to provide different types of entrepreneurs with management solutions for pharmaceutical R&D innovation and internal collaborative management, which is conducive to the analysis of advantages and disadvantages of entrepreneurs based on their own characteristics, and can effectively improve their ability of internal resource integration and independent innovation in drug R&D.

4.
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 177-183, 2020.
Article in Chinese | WPRIM | ID: wpr-872936

ABSTRACT

Traditional Chinese medicine (TCM), as the unique health resources, huge potential economic resources, scientific and technological resources with original advantages, excellent cultural resources and important ecological resources, has made remarkable achievements in Chinese economic and social development in recent years. However, there are still some problems in the reform and development of TCM, especially the lack of willingness to innovate and low ability in commercialization of research and development findings in such companies. Meanwhile, the globalization level of TCM is not high. All these problems have seriously restricted the overall development of TCM. Taking TCM enterprises as the research object, this paper uses SWOT analysis to carry out comprehensive strategic analysis on its advantages, disadvantages, opportunities and risks. It is concluded that TCM enterprises in China should focus on research and development of classical formula compound preparations and innovative TCM products, and then propose product development and innovation strategies.

5.
Acta Pharmaceutica Sinica ; (12): 687-691, 2019.
Article in Chinese | WPRIM | ID: wpr-780161

ABSTRACT

To expand an efficient strategy for the conversion of antibacterial activity of fluoroquinolones into an antitumor activity, sixteen new compounds, 1-cyclopropyl-6- fluoro-7-(4-methyl-piperazin-1-yl)-3-(5-arylidene-thiazol-4(5H)-one-2-yl)-quinolon-4(1H)-ones (7a-7p), were designed and synthesized with a thiazolone ring and an arylidene moiety as an isostere and modified group, respectively, from ciprofloxacin. Their structures were characterized by elemental analysis and spectral data. The in vitro antitumor activity of the synthesized compounds were measured using Hep-3B, Capan-1 and HL60 cell lines and were found to be more potent than ciprofloxacin. Meanwhile, the SAR revealed that the halogenated phenyl compounds such as fluorophenyl (7h, 7i), chlorophenyl (7j, 7k) or bromophenyl compounds (7l, 7m), and aromatic heterocyclic substitution such as furyl (6n) or pyridyl compounds (6o, 6p) displayed better activity than the control compounds, especially the IC50 values of pyridyl compounds 6o and 6p against Capan-1 cell growth was comparable to doxorubicin. Thus, an arylidene-modified thiazolone scaffold as the replacement of the C-3 carboxylic acid group appears to be an alternative route for an improved antitumor activity of fluoroquinolones.

6.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 782-790, 2018.
Article in English | WPRIM | ID: wpr-773561

ABSTRACT

A series of new hybrids of dehydroandrographolide (TAD), a biologically active natural product, bearing nitric oxide (NO)-releasing moieties were synthesized and designated as NO-donor dehydroandrographolide. The biological activities of target compounds were studied in human erythroleukemia K562 cells and breast cancer MCF-7 cells. Biological evaluation indicated that the most active compound I-5 produced high levels of NO and inhibited the proliferation of K562 (IC 1.55 μmol·L) and MCF-7 (IC 2.91 μmol·L) cells, which were more potent than the lead compound TAD and attenuated by an NO scavenger. In conclusion, I-5 is a novel hybrid with potent antitumor activity and may become a promising candidate for future intensive study.


Subject(s)
Humans , Antineoplastic Agents , Chemistry , Cell Proliferation , Diterpenes , Chemistry , Pharmacology , Drug Design , Drug Screening Assays, Antitumor , K562 Cells , MCF-7 Cells , Nitric Oxide , Chemistry , Pharmacology , Structure-Activity Relationship
7.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 782-790, 2018.
Article in English | WPRIM | ID: wpr-812350

ABSTRACT

A series of new hybrids of dehydroandrographolide (TAD), a biologically active natural product, bearing nitric oxide (NO)-releasing moieties were synthesized and designated as NO-donor dehydroandrographolide. The biological activities of target compounds were studied in human erythroleukemia K562 cells and breast cancer MCF-7 cells. Biological evaluation indicated that the most active compound I-5 produced high levels of NO and inhibited the proliferation of K562 (IC 1.55 μmol·L) and MCF-7 (IC 2.91 μmol·L) cells, which were more potent than the lead compound TAD and attenuated by an NO scavenger. In conclusion, I-5 is a novel hybrid with potent antitumor activity and may become a promising candidate for future intensive study.


Subject(s)
Humans , Antineoplastic Agents , Chemistry , Cell Proliferation , Diterpenes , Chemistry , Pharmacology , Drug Design , Drug Screening Assays, Antitumor , K562 Cells , MCF-7 Cells , Nitric Oxide , Chemistry , Pharmacology , Structure-Activity Relationship
8.
Chinese Medical Sciences Journal ; (4): 116-120, 2016.
Article in English | WPRIM | ID: wpr-281440

ABSTRACT

Great progresses have been made in fundamental and clinical stem cell research in China in recent years. The official policy on stem cells, which was announced in 2015, seems as the spring of stem cell therapy in China. However, the regulation, governance, and management of clinical expectations are still challenging. This review summarized the current stem cell research and development in the field, as well as its rapidly evolving commercial, regulatory and ethical environment in China. As expected, the prospects of stem cells in China look prospective.

9.
Acta Pharmaceutica Sinica ; (12): 1258-1262, 2015.
Article in Chinese | WPRIM | ID: wpr-320092

ABSTRACT

To discover an efficient strategy for the conversion of the antibacterial activity of fluoroquinolones into the antitumor activity, the three series of C-3 s-triazole-based derivatives including sulfide ketones (6a-6g), thiosemicarbazones (7a-7g) and fused heterocyclic thiazolotriazoles (8a-8g) were synthesized from ciprofloxacin (1), respectively. The structures were characterized by elemental analysis and spectral data. The antitumor activity was tested against three tumor cell lines (Hep-3B, Capan-1 and HL60) using the MTT assay. The three types of compounds all exhibited stronger anti-proliferative activities than ciprofloxacin in the test. The order of their activities was in compounds 7>8>6, and the order of selectivity against cancer cell lines was Capan-1, Hep-3B and HL60. Meanwhile, the SAR revealed that some compounds with electron-drawing group substituted such as fluoro- and nitro-phenyl compounds (6f, 7f, 8f) and (6g, 7g, 8g) displayed more significant activity than the control compounds, especially the IC50 values of thiosemicarbazone compounds 7f and 7g against Capan-1 was comparable to doxorubicin. Thus, a five-membered triazole as the C-3 bioisostere modified with the functionalized side-chain of sulfide-ketone thiosemicarbazone warrants special attention and further investigation.


Subject(s)
Humans , Anti-Bacterial Agents , Chemistry , Antineoplastic Agents , Pharmacology , Cell Line, Tumor , Ciprofloxacin , Chemistry , Doxorubicin , Pharmacology , HL-60 Cells , Ketones , Pharmacology , Sulfides , Pharmacology , Triazoles , Pharmacology
10.
Acta Pharmaceutica Sinica ; (12): 569-573, 2015.
Article in Chinese | WPRIM | ID: wpr-257100

ABSTRACT

To discover novel antitumor fluoroquinolone lead compounds from a rational modification for antibacterial fluoroquinolones, a fused heterocyclic ketone corresponding to thiazolo[2,3- b][1,2,4]triazolone used as a bioisosteric replacement of the C-3 carboxylic acid group of ciprofloxacin 1, and further modification by a Claisen condensation reaction with substituted benzaldehydes formed novel fluoroquinolone C-3 fuse heterocyclic α, β-unsaturated ketones as the title compounds (6a-6r), separately. The structures of eighteen title compounds were characterized by elemental analysis, 1H NMR and MS, and the in vitro anti-proliferative activity against human hepatoma Hep-3B cells, pancreatic Capan-1 cells and leukemia HL60 cells was evaluated by a MTT assay. The preliminary results showed that the title compounds not only had more significant anti-proliferative activity against three tested cancer cell lines than that of the parent ciprofloxacin 1, but also exhibited the highest activity against Capan-1 cells. In particular, compounds carrying an electron-withdrawing carboxyl (6k, 6m) or sulfonamide substituent (6q, 6r) attached to benzene ring were comparable to or better than constractive drug doxorubicin against Capan-1 cells. As such, it suggests that it is favorable for a fused heterocyclic α, β-unsaturated ketone scaffold instead of the C-3 carboxylic acid group to improve the antitumor activity of fluoroquinolones.


Subject(s)
Humans , Anti-Bacterial Agents , Antineoplastic Agents , Pharmacology , Cell Line, Tumor , Ciprofloxacin , Fluoroquinolones , Pharmacology , HL-60 Cells , Ketones , Pharmacology , Structure-Activity Relationship
11.
Acta Pharmaceutica Sinica ; (12): 1008-1012, 2015.
Article in Chinese | WPRIM | ID: wpr-257034

ABSTRACT

To discover novel antitumor rhodanine unsaturated ketones, a series of fluoroquinolone (rhodanine α, β-unsaturated ketone) amine derivatives (5a-5r) were designed and synthesized with fluoroquinolone amide scaffold as a carrier. The structures of eighteen title compounds were characterized by elemental analysis, 1H NMR and MS. The in vitro anti-proliferative activity against Hep-3B, Capan-1 and HL60 cells was evaluated by MTT assay. The results showed that the title compounds not only had more significant anti-proliferative activity against three tested cancer cell lines than that of the parent ciprofloxacin 1, but also exhibited the highest activity against Capan-1 cells. The SAR revealed that some compounds carrying aromatic heterocyclic rings or phenyl attached to an electron-withdrawing carboxyl or sulfonamide substituent were comparable to or better than comparison doxorubicin against Capan-1 cells. As such, it suggests that fluoroquinolone (rhodanine α, β-unsaturated ketone) amines are promising leads for the development of novel antitumor fluoroquinolones or rhodanine analogues.


Subject(s)
Humans , Amides , Pharmacology , Antineoplastic Agents , Pharmacology , Cell Line, Tumor , Fluoroquinolones , Pharmacology , HL-60 Cells , Ketones , Pharmacology , Rhodanine , Pharmacology
12.
Acta Pharmaceutica Sinica ; (12): 332-336, 2015.
Article in Chinese | WPRIM | ID: wpr-251775

ABSTRACT

To discover novel fluoroquinolone lead compounds as possible anti-infective or/and antitumor chemotherapies, combination principle of pharmacophore-based drug design, a series of novel tricyclic fluoroquinolone title compounds, [1,2,4]triazino[3,4-h][1,8]naphthyridine-8-one-7-carboxylic acid derivatives ( 5a-5p), were designed and synthesized with a fused [1,2,4]-triazine ring unit. Their structures were characterized by spectral data and elemental analysis and the in vitro antibacterial and anti-cell proliferation activities were also evaluated. The results showed that the titled compounds exhibited more significant inhibitory activities against drug-resistant bacteria (Methicillin-resistant Staphylococcus aureus and multi drug-resistant Escherichia coli strains) and three tested cancer cell lines (human hepatoma SMMC-7721, murine leukemia L1210 and human murine leukemia HL60 cells). Interestingly, SAR showed that compounds with electron-donating groups attached to benzene ring had stronger antibacterial activity than antitumor activity, but electron-withdrawing compounds displayed more potential antitumor activity than antibacterial activity, especially antitumor activity of nitro compounds was comparable to comparison doxorubicin. Thus, novel triazine-fused tricyclic fluoroquinolones as potent anti-infective or/and antitumor lead compounds are valuable to pay attention and for further development.


Subject(s)
Animals , Humans , Mice , Anti-Bacterial Agents , Chemistry , Antineoplastic Agents , Chemistry , Carboxylic Acids , Carcinoma, Hepatocellular , Cell Line , Cell Proliferation , Drug Design , Escherichia coli , Fluoroquinolones , Chemistry , HL-60 Cells , Leukemia L1210 , Liver Neoplasms , Methicillin-Resistant Staphylococcus aureus , Naphthyridines , Triazines
13.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 613-618, 2014.
Article in English | WPRIM | ID: wpr-812226

ABSTRACT

AIM@#To identify the glucose lowering ability and chronic treatment effects of a novel coumarin-glucagon-like peptide-1 (GLP-1) conjugate HJ07.@*METHOD@#A receptor activation experiment was performed in HEK 293 cells and the glucose lowering ability was evaluated with hypoglycemic duration and glucose stabilizing tests. Chronic treatment was performed by daily injection of exendin-4, saline, and HJ07. Body weight and HbA1c were measured every week, and an intraperitoneal glucose tolerance test was performed before treatment and after treatment.@*RESULTS@#HJ07 showed well-preserved receptor activation efficacy. The hypoglycemic duration test showed that HJ07 possessed a long-acting, glucose-lowering effect and the glucose stabilizing test showed that the antihyperglycemic activity of HJ07 was still evident at a predetermined time (12 h) prior to the glucose challenge (0 h). The long time glucose-lowering effect of HJ07 was better than native GLP-1 and exendin-4. Furthermore, once daily injection of HJ07 to db/db mice achieved long-term beneficial effects on HbA1c lowering and glucose tolerance.@*CONCLUSION@#The biological activity results of HJ07 suggest that HJ07 is a potential long-acting agent for the treatment of type 2 diabetes.


Subject(s)
Animals , Humans , Male , Blood Glucose , Metabolism , Coumarins , Pharmacology , Diabetes Mellitus , Blood , Drug Therapy , Diabetes Mellitus, Type 2 , Drug Therapy , Exenatide , Glucagon-Like Peptide 1 , Pharmacology , Therapeutic Uses , Glucagon-Like Peptide-1 Receptor , Glucose Tolerance Test , Glycated Hemoglobin , Metabolism , HEK293 Cells , Hypoglycemic Agents , Pharmacology , Therapeutic Uses , Mice, Inbred C57BL , Mice, Knockout , Peptides , Pharmacology , Receptors, Glucagon , Metabolism , Venoms , Pharmacology
14.
Acta Pharmaceutica Sinica ; (12): 1694-1698, 2014.
Article in Chinese | WPRIM | ID: wpr-251834

ABSTRACT

To explore an efficient strategy for the conversion of antibacterial fluoroquinolones into antitumor fluoroquinolones, an azole heterocyclic ring of oxadiazole instead of the C-3 carboxylic acid group with a functionalized hydrazone group as a modified side-chain, fifteen novel 2-(fluoroquinolon-3-yl)-oxadiazole-5- sulfanylacetylhydrazone derivatives 7a-7o were designed and synthesized on the basis of the pharmacophore hybridization principle from pefloxacin, separately. The structures for fifteen title compounds were characterized by elemental analysis, 1H NMR and MS, and their in vitro antitumor activity against Hep-3B cell line was evaluated by a MTT assay. The results showed that the title compounds exhibited more significantly inhibitory activity than that of the parent pefloxacin, in which compounds with electron-withdrawing group attached on aryl ring had more potency than that of compounds with electron donating group, especially compounds with a carboxylic substituent were comparable to comparison doxorubicin. It suggests that it is favorable for an improvement of antitumor activity to remain a carboxylic acid unit at the aromatic ring.


Subject(s)
Humans , Antineoplastic Agents , Chemistry , Cell Line, Tumor , Fluoroquinolones , Chemistry , Oxadiazoles , Chemistry , Structure-Activity Relationship
15.
Acta Pharmaceutica Sinica ; (12): 372-376, 2013.
Article in Chinese | WPRIM | ID: wpr-235657

ABSTRACT

According to the structure-activity relationships (SARs) of modafinil, a therapeutic drug of hypnolepsy, we designed and synthesized two series of compounds 2-[(diphenylmethane)sulfinyl] acetamides and 2-[(diphenylmethyl)thio] acetamides, and measured their biological activities. The target compounds (6a-6o) were synthesized beginning with diphenyl carbinol by substitution, oxidation, acylation and so on. Their structures were confirmed by ESI-MS, 1H NMR and elemental analysis. The central stimulatory effects of the target compounds were determined by the independent activity assay on mice. Compounds 6c, 6f and 6n have considerable activities, while the central stimulative effect of 6h is slightly better than the positive control modafinil.


Subject(s)
Animals , Mice , Acetamides , Chemistry , Pharmacology , Behavior, Animal , Benzhydryl Compounds , Chemistry , Pharmacology , Biphenyl Compounds , Chemistry , Pharmacology , Methane , Chemistry , Pharmacology , Mice, Inbred ICR , Random Allocation , Structure-Activity Relationship , Wakefulness-Promoting Agents , Chemistry , Pharmacology
16.
Acta Pharmaceutica Sinica ; (12): 66-71, 2012.
Article in Chinese | WPRIM | ID: wpr-323079

ABSTRACT

An efficient modified route based on the targeting mechanism of antibacterial fluoroquinolones for the shift from the antibacterial activity to the antitumor one was further developed. Using a fused heterocyclic ring, s-triazolothiadiazine as a carboxyl bioisostere of ciprofloxacin, the title compounds, 1-cyclopropyl-6-fluoro-7-piperazin-1-yl-3-(6-substituted-phenyl-7H-[1, 2, 4]triazolo[3, 4-b][1, 3, 4]thiadiazin-3-yl)-quinolin-4(1H)-ones (5a-5e) and their corresponding N-acetyl products (6a-6e), were designed and synthesized, separately. Meaningfully, a ring-contraction of fused six-membered thiadiazine occurred by a sulfur extrusion reaction gave new tri-acetylated fused heterocycles related to pyrazolo[5, 1-c][1, 2, 4] triazoles (7a-7e). The in vitro antitumor activity against L1210, CHO and HL60 cell lines was also evaluated for the synthesized fifteen heterocycles compared to parent ciprofloxacin by methylthiazole trazolium (MTT) assay. Interestingly, the results displayed that fifteen fused heterocyclic compounds showed more significant growth inhibitory activity (IC50 < 25.0 micromo x L(-1)) than that of parent ciprofloxacin (IC50 > 150.0 micromol x L(-1)), and the active order decreased from 7a-7e to 5a-5e to 6a-6e, respective.


Subject(s)
Animals , Cricetinae , Humans , Mice , Antineoplastic Agents , Chemistry , Pharmacology , CHO Cells , Cell Line, Tumor , Ciprofloxacin , Pharmacology , Cricetulus , Fluoroquinolones , Chemistry , Pharmacology , HL-60 Cells , Inhibitory Concentration 50 , Leukemia L1210 , Pathology , Structure-Activity Relationship , Thiadiazines , Chemistry , Pharmacology , Triazoles , Chemistry , Pharmacology
17.
Acta Pharmaceutica Sinica ; (12): 1017-1022, 2012.
Article in English | WPRIM | ID: wpr-276206

ABSTRACT

To explore an efficient strategy for further development of anticancer fluoroquinolone candidates derived from ciprofloxacin, a heterocyclic ring as the bioisosteric replacement of C3 carboxyl group led to a key intermediate, oxadiazole thiol (5), which was further modified to the bis-oxadiazole methylsulfides (7a-7h) and the corresponding dimethylpiperazinium iodides (8a-8h), respectively. Structures were characterized by elemental analysis and spectra data, and their anticancer activities in vitro against CHO, HL60 and L1210 cancer cells were also evaluated by MTT assay. The preliminary results show that piperazinium compounds (8) possess more potent activity than that of corresponding free bases (7).


Subject(s)
Animals , Cricetinae , Humans , Antineoplastic Agents , Chemistry , Pharmacology , CHO Cells , Cell Line, Tumor , Cell Proliferation , Ciprofloxacin , Chemistry , Cricetulus , Drug Design , HL-60 Cells , Inhibitory Concentration 50 , Leukemia L1210 , Molecular Structure , Oxadiazoles , Chemistry , Pharmacology , Piperazines , Chemistry , Pharmacology
18.
Acta Pharmaceutica Sinica ; (12): 1012-1016, 2010.
Article in English | WPRIM | ID: wpr-250647

ABSTRACT

To develop a new small molecular probe for discovering an antitumor lead compound from the replacement of carboxylic group of two molecular antibacterial fluoroquinolones with a heterocyclic ring, a series of the C3/C3 bis-fluoroquinolones tethered with an 1, 3, 4-oxadiazole ring were synthesized as their respective HCl salts, and their structures were characterized by elemental analysis and spectral data. The in vitro antitumor activity against L1210, CHO and HL60 cell lines was also evaluated via the respective IC50 values by methylthiazole trazolium (MTT) assay.


Subject(s)
Animals , Cricetinae , Humans , Antineoplastic Agents , Chemistry , Pharmacology , CHO Cells , Cell Line, Tumor , Cricetulus , Drug Design , Fluoroquinolones , Chemistry , Pharmacology , HL-60 Cells , Inhibitory Concentration 50 , Leukemia L1210 , Pathology , Molecular Structure , Oxadiazoles , Chemistry , Pharmacology , Structure-Activity Relationship
19.
Acta Pharmaceutica Sinica ; (12): 50-53, 2008.
Article in Chinese | WPRIM | ID: wpr-268174

ABSTRACT

To find out a novel lead compound from heterocyclic amine Schiff bases for developing new antitumor agents, each of (4-amino-5-substituted-s-triazol-3-ylthio) -acetic acids 2a-j was condensed with anthracene-9-carbaldehyde to obtain Schiff-bases of [4-(anthracen-9-yl methylene) amino] -5-substituted-s-triazol-3-ylsulfanyl] -acetic acids 3a-j. The structures of new compounds synthesized were characterized by elemental analysis and spectral data, and in vitro antitumor activity was also evaluated against CHO, HL60 and L1210 cell lines by MTT assay.


Subject(s)
Animals , Cricetinae , Humans , Mice , Acetic Acid , Chemistry , Anthracenes , Chemistry , Antineoplastic Agents , Chemistry , Pharmacology , CHO Cells , Cricetulus , HL-60 Cells , Leukemia L1210 , Pathology , Molecular Structure , Schiff Bases , Chemistry , Pharmacology , Triazoles , Chemistry , Pharmacology
20.
Acta Pharmaceutica Sinica ; (12): 926-929, 2008.
Article in Chinese | WPRIM | ID: wpr-232667

ABSTRACT

To optimize the synthetic method and antibacterial activity of fused heterocyclic thiadiazole compounds, cyclocondensation of 2-(4-methoxyphenyl)-5-amino-1,3,4-thiadiazole (2) with alpha-chloro-4-chloro acetophenone (3) resulted in a key intermediate (4), 6 -(4-chlorophenyl)-2-(4-methoxyphenyl)-imidazo-[2,1-b][1,3,4]thiadiazole, which was carried out an nucleophilic substitution with substituted piperazine to give the corresponding free bases of piperazine (5a-5c), then followed by Mannich reaction with heterocyclicamines and formaldehyde to yield the corresponding Mannich bases, (1a-11) as respective hydrochloride salts. The structures were confirmed by IR, 1H NMR, MS and elemental analysis and the antibacterial activities in vitro of fifteen newly synthesized compounds were also tested against Gram positive bacteria and Gram negative bacteria with the standard 2-fold agar dilution method. The antibacterial results showed that the introduction of a polar group resulted in the enhancement of antibacterial activity in vitro. Thus, the structures of these fused compounds could further be investigated.


Subject(s)
Anti-Bacterial Agents , Chemistry , Pharmacology , Bacillus subtilis , Escherichia coli , Imidazoles , Chemistry , Pharmacology , Mannich Bases , Chemistry , Microbial Sensitivity Tests , Molecular Structure , Pseudomonas aeruginosa , Staphylococcus aureus , Thiadiazoles , Chemistry , Pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL